Assignee
NAPIGEN INC
US·2 granted patents·6 pending applications·3 citations·filing 2018–2024
Top patents by PatentIndex Score
8 records- 0194US11920140B2Organelle genome modification using polynucleotide guided endonucleaseNAPIGEN INC·Filed 2022·Granted Mar 5, 2024·3 cites·14 claims
- 0287US2025137003A1Organelle genome modification using polynucleotide guided endonucleaseNAPIGEN INC·Filed 2024·Application pending·0 cites
- 0386US12173295B2Organelle genome modification using polynucleotide guided endonucleaseNAPIGEN INC·Filed 2024·Granted Dec 24, 2024·0 cites·19 claims
- 0470US2025027099A1Phosphite dehydrogenase as a selectable marker for mitochondrial transformationNAPIGEN INC·Filed 2022·Application pending·0 cites
- 0569US2023175003A1Phosphite dehydrogenase as a selectable marker for mitochondrial transformationNAPIGEN INC·Filed 2022·Application pending·0 cites
- 0667US2019136249A1Organelle genome modification using polynucleotide guided endonucleaseNAPIGEN INC·Filed 2018·Application pending·0 cites
- 0767US2021054404A1Organelle genome modification using polynucleotide guided endonucleaseNAPIGEN INC·Filed 2018·Application pending·0 cites
- 0859US2022372523A1Organelle genome modificationNAPIGEN INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAPIGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →